End‐of‐Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration

Journal of the American Geriatrics Society

Fecha de publicación: 24 de diciembre de 2020

Autores: Risha Gidwani, DrPHSteven M. Asch MD, MPHJack Needleman PhDKatherine Faricy‐Anderson MD, MPHDerek B. Boothroyd PhDSamantha Illarmo MPHKarl A. Lorenz MD, MSManali I. Patel MD, MS, MPHGary Hsin MDKavitha Ramchandran MDTodd H. Wagner PhD

DOI: https://doi.org/10.1111/jgs.17052

Background: To evaluate differences in end‐of‐life cost trajectories for cancer patients treated through Medicare versus by the Veterans Health Administration (VA). Design: A retrospective analysis of VA and Medicare administrative data from FY 2010 to 2014. We employed three‐level generalized estimating equations to evaluate monthly cost trajectories experienced by patients in their last year of life, with patients nested within hospital referral region.

Enviar comentario